INBRAIN Neuroelectronics Named 2025 World Economic Forum Technology Pioneer
BARCELONA, Spain--(BUSINESS WIRE)-- INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision brain-computer interfaces (BCIs) powered by graphene, today announced it has been selected as a 2025 Technology Pioneer by the World Economic Forum. The prestigious recognition highlights INBRAIN's groundbreaking work developing intelligent neuroelectronic therapies using graphene to treat neurological disorders with unprecedented precision.
Founded in 2020, INBRAIN is pioneering a new class of BCI therapeutics built with graphene, a biocompatible material that enables ultra-thin, minimally invasive implants capable of decoding and modulating brain signals in real time at micrometric precision. The company's platform is built to deliver autonomous therapeutics for neurological conditions such as epilepsy, Parkinson's disease, and stroke rehabilitation, using real-time neural data to personalize treatment and ultimately enable reimbursement based on outcomes.
'We are honored to be recognized as a Technology Pioneer by the World Economic Forum,' said Carolina Aguilar, Ph.D., Co-Founder and CEO of INBRAIN Neuroelectronics. 'This award validates our vision to build a new standard of care for patients with neurological disorders, one that is adaptive, precise, and grounded in both data and biology.'
Each year, the World Economic Forum selects a limited number of early-stage companies from around the world that are redefining industries through breakthrough technologies and bold business models; past recipients include companies in AI, biotech, and tech, such as Google.
As a 2025 Technology Pioneer, INBRAIN will engage directly with global leaders and policymakers at key Forum gatherings, contributing to initiatives that shape the future of health, neurotechnology, and precision medicine. This year's cohort includes 100 innovative startups, with upcoming opportunities to connect at the Annual Meeting of the New Champions in Tianjin, China, and a community convening in New York this December.
INBRAIN was recently awarded a €4 million grant by the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative. The grant will accelerate INBRAIN's development of BCI technology that integrates intelligent computing and graphene-based materials to decode and modulate real time brain activity for therapeutic purposes.
About INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is advancing real-time precision neurology with the world's first graphene-based brain-computer interface therapeutics (BCI-Tx) platform. Using high-resolution neural decoding and targeted micromodulation, INBRAIN delivers personalized, adaptive treatments for neurological conditions like Parkinson's disease, epilepsy, and stroke rehabilitation. The company is developing autonomous BCI therapeutics that continuously monitor and adjust therapy in real time to enhance outcomes and minimize side effects, and has earned FDA Breakthrough Device Designation for its application in Parkinson's disease. In partnership with Merck KGaA and through its subsidiary INNERVIA Bioelectronics, INBRAIN is also developing bioelectronic therapies for peripheral and systemic diseases. Learn more at www.inbrain-neuroelectronics.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Cybersecurity Giant Palo Alto Networks Caught Between Opportunity and Maturity
As the world's largest standalone cybersecurity company, Palo Alto Networks has potentially much to gain from a splintering world. Not to mention, its stock offers a relatively unfiltered view of investor confidence in the sector. But while the company has risen nearly 9% so far this year, and some analysts are gung ho, a look under the hood suggests that astronomical growth can't carry on forever, even if geopolitics feels like a dice roll in a game of Risk at the moment. READ ALSO: Amazon's Driverless Cab Company Zoox Revs Up 'Toaster Taxis' and 'Uncertain' 2025, M&A Deadlock Freeze $1 Trillion in PE Assets Back in January, almost 60% of organizations including private companies told the World Economic Forum that geopolitical tensions have impacted their cybersecurity strategies. Many are also on edge about risks: One in three CEOs said they were worried about losing sensitive information or intellectual property to cyber-espionage, and 45% of cyber leaders expressed concern about operational and business disruptions. The rise of state-sanctioned cyberattacks, with China and Russia the best-known sponsors, and recent warnings to US companies to prep for potential cyberattacks from Iran have inflamed tensions. All that suggests a market for Palo Alto Networks to grow into, what with its next-generation firewalls, cloud security services and AI-powered security operations. Goldman Sachs analysts are among those who see this logic: They maintained a buy rating on the company earlier this month, citing its revenue growth of roughly 14% in the past 12 months and its success in selling new products to existing customers. But, on the other hand, there's a maturity challenge: Palo Alto Networks sales growth has slowed — its revenue growth was in the mid-20s percentage points in 2023, and its latest quarter saw revenues grow 15.7% year over year. Meanwhile, the growth of annual recurring revenue — which offers a glimpse into the company's ability to retain customers — has declined in five straight quarters, and it's expected to be around 32% this year, compared with 45% or more in previous years. Even as Palo Alto beat revenue and earnings expectations in its latest quarter, the slowdown suggests the company may be maturing and reaching a plateau where customer adoption is slowing —a reality that cybersecurity firms will have to learn to live with, as other industries have. Nevertheless, the sector is expected to grow by hundreds of billions of dollars in the next decade, meaning there will be plenty of dollars to compete for, but likely more competitors. Palo Alto, at the very least, proved more resilient during a week of concerns about conflict with Iran than the broader tech industry. Its shares rose 0.8% last week, while the iShares Expanded Tech-Software Sector ETF fell 1.8% over the same period. Hitting the Firewall: Nikesh Arora, the CEO of Palo Alto Networks, makes a living putting up firewalls, but he also knows the feeling of rejection. He told the Humans of Bombay podcast earlier this month that after graduating from university, he was rejected from more than 400 jobs. 'I saved all the rejection letters,' he said. 'They're my motivation.' This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter. Sign in to access your portfolio
Business Wire
6 hours ago
- Business Wire
INBRAIN Neuroelectronics Named 2025 World Economic Forum Technology Pioneer
BARCELONA, Spain--(BUSINESS WIRE)-- INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision brain-computer interfaces (BCIs) powered by graphene, today announced it has been selected as a 2025 Technology Pioneer by the World Economic Forum. The prestigious recognition highlights INBRAIN's groundbreaking work developing intelligent neuroelectronic therapies using graphene to treat neurological disorders with unprecedented precision. Founded in 2020, INBRAIN is pioneering a new class of BCI therapeutics built with graphene, a biocompatible material that enables ultra-thin, minimally invasive implants capable of decoding and modulating brain signals in real time at micrometric precision. The company's platform is built to deliver autonomous therapeutics for neurological conditions such as epilepsy, Parkinson's disease, and stroke rehabilitation, using real-time neural data to personalize treatment and ultimately enable reimbursement based on outcomes. 'We are honored to be recognized as a Technology Pioneer by the World Economic Forum,' said Carolina Aguilar, Ph.D., Co-Founder and CEO of INBRAIN Neuroelectronics. 'This award validates our vision to build a new standard of care for patients with neurological disorders, one that is adaptive, precise, and grounded in both data and biology.' Each year, the World Economic Forum selects a limited number of early-stage companies from around the world that are redefining industries through breakthrough technologies and bold business models; past recipients include companies in AI, biotech, and tech, such as Google. As a 2025 Technology Pioneer, INBRAIN will engage directly with global leaders and policymakers at key Forum gatherings, contributing to initiatives that shape the future of health, neurotechnology, and precision medicine. This year's cohort includes 100 innovative startups, with upcoming opportunities to connect at the Annual Meeting of the New Champions in Tianjin, China, and a community convening in New York this December. INBRAIN was recently awarded a €4 million grant by the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative. The grant will accelerate INBRAIN's development of BCI technology that integrates intelligent computing and graphene-based materials to decode and modulate real time brain activity for therapeutic purposes. About INBRAIN Neuroelectronics INBRAIN Neuroelectronics is advancing real-time precision neurology with the world's first graphene-based brain-computer interface therapeutics (BCI-Tx) platform. Using high-resolution neural decoding and targeted micromodulation, INBRAIN delivers personalized, adaptive treatments for neurological conditions like Parkinson's disease, epilepsy, and stroke rehabilitation. The company is developing autonomous BCI therapeutics that continuously monitor and adjust therapy in real time to enhance outcomes and minimize side effects, and has earned FDA Breakthrough Device Designation for its application in Parkinson's disease. In partnership with Merck KGaA and through its subsidiary INNERVIA Bioelectronics, INBRAIN is also developing bioelectronic therapies for peripheral and systemic diseases. Learn more at
CNBC
a day ago
- CNBC
The lookahead: What next after U.S. strikes on Iran and Europe's 5% defense problem
After a week of global market jitters, the reaction to U.S. strikes on Iranian nuclear facilities will be front and center over the coming days. Meanwhile, a trio of heavyweight events could also shape the economic and geopolitical mood. From NATO tensions in The Hague to trade talks in Tianjin and industrial optimism in Berlin — investors will be watching closely. Addressing the nation on Saturday evening, U.S. President Donald Trump said strikes on three of Iran's nuclear sites were a "spectacular military success" that "completely obliterated" the country's major enrichment facilities. The strikes, which mark the first time the U.S. has conducted a direct military attack on Iran, mark a dramatic escalation in geopolitical tensions. Trump's claim about the result of the operation could not be independently confirmed. Iran Foreign Minister Abbas Araghchi slammed the U.S. strikes, describing them as "outrageous" and saying the country "reserves all options to defend its sovereignty, interest, and people." Global investors will be scrambling to assess the fallout. NATO meetings with Trump in attendance have a history of being dramatic. Back in 2017, the White House leader consistently questioned America's commitment to the alliance, and accused other members of owing "massive amounts of money" to the overall share of defense spending. Fast forward to 2025 and the next NATO Leaders Summit with Trump is set to take place in The Hague, the Netherlands on Wednesday. Some problems are familiar – while defense spending has increased dramatically across Europe, countries like Spain risk derailing talks by calling the 5% of GDP target "unreasonable." In addition, the war in Ukraine rages on. Meanwhile other problems are new – hostilities are rising between Israel and Iran, alongside other neighbors in the Middle East, are testing international relations to the limit. U.S. Ambassador to NATO Matthew Whittaker, told CNBC's "Squawk Box Europe" that the region should not expect a free ride from the U.S. on defense spending, as "the 5% target is not a negotiating tactic." On the other side of the world, the Chinese city of Tianjin plays host to the World Economic Forum's Meeting of New Champions running from Tuesday to Thursday, also known as the Summer Davos. Technology dominates the agenda at a tricky time for relations between China and the West, as trade negotiations with the U.S. are still on-going. Trump may have bought more time for TikTok, extending the deadline for China's ByteDance to divest the social media platform's U.S. business to September, but the latest round of trade talks in London led to a vague stand-off between the two superpowers, with no official readout. Speaking to CNBC right after those negotiations, U.S .Commerce Secretary Howard Lutnick was asked if current tariffs on China would not shift again, to which he replied, "you can definitely say that." But this may do little to ease the conversations between Chinese officials and corporates in Tianjin, and the international delegates in attendance, who will be looking for more certainty from both the White House and Beijing. Closer to home, it's the Day of Industry conference in Germany on Monday and Tuesday. This annual meeting in Berlin highlights German economic policy and global trade strategies. It could be a good time for the new government to be touting Europe's so-called Engine of Growth, with four economic institutes raising their 2025 and 2026 GDP growth forecasts for Europe's largest economy. During a recent trip to Washington DC, Chancellor Friedrich Merz dodged the ire that other world leaders have faced in the Oval Office, with Trump's focus mostly dominated by his public spat with Elon Musk. But it's not all clear roads ahead for Germany, as the country's auto industry body reports that domestic auto-makers have shouldered around 500 million euros ($576.1 million) in costs associated with Trump's import tariffs.
